Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications

Rheumatology (Oxford). 2013 Sep;52(9):1731-2. doi: 10.1093/rheumatology/ket121. Epub 2013 Mar 12.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Child, Preschool
  • Cryopyrin-Associated Periodic Syndromes / drug therapy*
  • Humans
  • Infant
  • Male
  • Treatment Failure

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab